 | • レポートコード：QY2108PAL8529 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：1日） • 産業分類：医療装置 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける血液灌流の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、血液灌流の種類別市場規模（活性炭吸着、樹脂吸着）、用途別市場規模（肝性脳症、特定自己免疫疾患、薬物過剰摂取、特定中毒、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の血液灌流市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における血液灌流の種類別市場規模（2016年-2027年）：活性炭吸着、樹脂吸着 ・世界における血液灌流の用途別市場規模（2016年-2027年）：肝性脳症、特定自己免疫疾患、薬物過剰摂取、特定中毒、その他 ・血液灌流の中国市場分析 - 血液灌流の中国市場規模（2016年-2027年） - 中国における血液灌流の主要プレイヤー別市場シェア - 中国における血液灌流の種類別市場規模：活性炭吸着、樹脂吸着 - 中国における血液灌流の用途別市場規模：肝性脳症、特定自己免疫疾患、薬物過剰摂取、特定中毒、その他 ・血液灌流の北米市場（2016年-2027年） ・血液灌流のヨーロッパ市場（2016年-2027年） ・血液灌流のアジア太平洋市場（2016年-2027年） ・血液灌流の中南米市場（2016年-2027年） ・血液灌流の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Jafron Biomedical、Baxter (Gambro)、Asahi-Kasei、Biosun Medical、Kaneka、Toray Medical、Cytosorbents、Aier、Zibo Kangbei ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Hemoperfusion is a treatment technique in which large volumes of the patient’s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.
Market Analysis and Insights: Global and China Hemoperfusion Market
This report focuses on global and China Hemoperfusion market.
In 2020, the global Hemoperfusion market size was US$ 421 million and it is expected to reach US$ 1359.3 million by the end of 2027, with a CAGR of 18.1% during 2021-2027. In China the Hemoperfusion market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Hemoperfusion Scope and Market Size
Hemoperfusion market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hemoperfusion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Hemoperfusion market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Hepatic Encephalopathy occupies the largest market share of Hepatic Encephalopathy and is the fastest growing
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
1 Study Coverage
1.1 Hemoperfusion Product Introduction
1.2 Market by Type
1.2.1 Global Hemoperfusion Market Size Growth Rate by Type
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Market by Application
1.3.1 Global Hemoperfusion Market Size Growth Rate by Application
1.3.2 Hepatic Encephalopathy
1.3.3 Certain Autoimmune Diseases
1.3.4 Drug Overdose
1.3.5 Specific Intoxications
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemoperfusion Market Size, Estimates and Forecasts
2.1.1 Global Hemoperfusion Revenue 2016-2027
2.1.2 Global Hemoperfusion Sales 2016-2027
2.2 Global Hemoperfusion, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hemoperfusion Historical Market Size by Region (2016-2021)
2.3.1 Global Hemoperfusion Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hemoperfusion Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hemoperfusion Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hemoperfusion Sales Forecast by Region (2022-2027)
2.4.2 Global Hemoperfusion Revenue Forecast by Region (2022-2027)
3 Global Hemoperfusion Competitor Landscape by Players
3.1 Global Top Hemoperfusion Manufacturers by Sales
3.1.1 Global Hemoperfusion Sales by Manufacturer (2016-2021)
3.1.2 Global Hemoperfusion Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hemoperfusion Manufacturers by Revenue
3.2.1 Key Hemoperfusion Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hemoperfusion Revenue by Manufacturers (2016-2021)
3.2.3 Global Hemoperfusion Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hemoperfusion Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hemoperfusion Revenue in 2020
3.2.6 Global Hemoperfusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hemoperfusion Price by Manufacturers
3.4 Global Hemoperfusion Manufacturing Base Distribution, Product Types
3.4.1 Hemoperfusion Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemoperfusion Product Type
3.4.3 Date of International Manufacturers Enter into Hemoperfusion Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hemoperfusion Market Size by Type (2016-2021)
4.1.1 Global Hemoperfusion Sales by Type (2016-2021)
4.1.2 Global Hemoperfusion Revenue by Type (2016-2021)
4.1.3 Hemoperfusion Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hemoperfusion Market Size Forecast by Type (2022-2027)
4.2.1 Global Hemoperfusion Sales Forecast by Type (2022-2027)
4.2.2 Global Hemoperfusion Revenue Forecast by Type (2022-2027)
4.2.3 Hemoperfusion Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hemoperfusion Market Size by Application (2016-2021)
5.1.1 Global Hemoperfusion Sales by Application (2016-2021)
5.1.2 Global Hemoperfusion Revenue by Application (2016-2021)
5.1.3 Hemoperfusion Price by Application (2016-2021)
5.2 Hemoperfusion Market Size Forecast by Application (2022-2027)
5.2.1 Global Hemoperfusion Sales Forecast by Application (2022-2027)
5.2.2 Global Hemoperfusion Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemoperfusion Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Hemoperfusion Market Size YoY Growth 2016-2027
6.1.1 China Hemoperfusion Sales YoY Growth 2016-2027
6.1.2 China Hemoperfusion Revenue YoY Growth 2016-2027
6.1.3 China Hemoperfusion Market Share in Global Market 2016-2027
6.2 China Hemoperfusion Market Size by Players (International and Local Players)
6.2.1 China Top Hemoperfusion Players by Sales (2016-2021)
6.2.2 China Top Hemoperfusion Players by Revenue (2016-2021)
6.3 China Hemoperfusion Historic Market Review by Type (2016-2021)
6.3.1 China Hemoperfusion Sales Market Share by Type (2016-2021)
6.3.2 China Hemoperfusion Revenue Market Share by Type (2016-2021)
6.3.3 China Hemoperfusion Price by Type (2016-2021)
6.4 China Hemoperfusion Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hemoperfusion Sales Forecast by Type (2022-2027)
6.4.2 China Hemoperfusion Revenue Forecast by Type (2022-2027)
6.4.3 China Hemoperfusion Price Forecast by Type (2022-2027)
6.5 China Hemoperfusion Historic Market Review by Application (2016-2021)
6.5.1 China Hemoperfusion Sales Market Share by Application (2016-2021)
6.5.2 China Hemoperfusion Revenue Market Share by Application (2016-2021)
6.5.3 China Hemoperfusion Price by Application (2016-2021)
6.6 China Hemoperfusion Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hemoperfusion Sales Forecast by Application (2022-2027)
6.6.2 China Hemoperfusion Revenue Forecast by Application (2022-2027)
6.6.3 China Hemoperfusion Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hemoperfusion Market Size YoY Growth 2016-2027
7.2 North America Hemoperfusion Market Facts & Figures by Country
7.2.1 North America Hemoperfusion Sales by Country (2016-2021)
7.2.2 North America Hemoperfusion Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hemoperfusion Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hemoperfusion Market Facts & Figures by Region
8.2.1 Asia Pacific Hemoperfusion Sales by Region (2016-2021)
8.2.2 Asia Pacific Hemoperfusion Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Hemoperfusion Market Size YoY Growth 2016-2027
9.2 Europe Hemoperfusion Market Facts & Figures by Country
9.2.1 Europe Hemoperfusion Sales by Country (2016-2021)
9.2.2 Europe Hemoperfusion Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hemoperfusion Market Size YoY Growth 2016-2027
10.2 Latin America Hemoperfusion Market Facts & Figures by Country
10.2.1 Latin America Hemoperfusion Sales by Country (2016-2021)
10.2.2 Latin America Hemoperfusion Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hemoperfusion Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hemoperfusion Market Facts & Figures by Country
11.2.1 Middle East and Africa Hemoperfusion Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hemoperfusion Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Jafron Biomedical
12.1.1 Jafron Biomedical Corporation Information
12.1.2 Jafron Biomedical Description and Business Overview
12.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jafron Biomedical Hemoperfusion Products Offered
12.1.5 Jafron Biomedical Recent Development
12.2 Baxter (Gambro)
12.2.1 Baxter (Gambro) Corporation Information
12.2.2 Baxter (Gambro) Description and Business Overview
12.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter (Gambro) Hemoperfusion Products Offered
12.2.5 Baxter (Gambro) Recent Development
12.3 Asahi-Kasei
12.3.1 Asahi-Kasei Corporation Information
12.3.2 Asahi-Kasei Description and Business Overview
12.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Asahi-Kasei Hemoperfusion Products Offered
12.3.5 Asahi-Kasei Recent Development
12.4 Biosun Medical
12.4.1 Biosun Medical Corporation Information
12.4.2 Biosun Medical Description and Business Overview
12.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biosun Medical Hemoperfusion Products Offered
12.4.5 Biosun Medical Recent Development
12.5 Kaneka
12.5.1 Kaneka Corporation Information
12.5.2 Kaneka Description and Business Overview
12.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kaneka Hemoperfusion Products Offered
12.5.5 Kaneka Recent Development
12.6 Toray Medical
12.6.1 Toray Medical Corporation Information
12.6.2 Toray Medical Description and Business Overview
12.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Toray Medical Hemoperfusion Products Offered
12.6.5 Toray Medical Recent Development
12.7 Cytosorbents
12.7.1 Cytosorbents Corporation Information
12.7.2 Cytosorbents Description and Business Overview
12.7.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cytosorbents Hemoperfusion Products Offered
12.7.5 Cytosorbents Recent Development
12.8 Aier
12.8.1 Aier Corporation Information
12.8.2 Aier Description and Business Overview
12.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Aier Hemoperfusion Products Offered
12.8.5 Aier Recent Development
12.9 Zibo Kangbei
12.9.1 Zibo Kangbei Corporation Information
12.9.2 Zibo Kangbei Description and Business Overview
12.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zibo Kangbei Hemoperfusion Products Offered
12.9.5 Zibo Kangbei Recent Development
12.11 Jafron Biomedical
12.11.1 Jafron Biomedical Corporation Information
12.11.2 Jafron Biomedical Description and Business Overview
12.11.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Jafron Biomedical Hemoperfusion Products Offered
12.11.5 Jafron Biomedical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hemoperfusion Industry Trends
13.2 Hemoperfusion Market Drivers
13.3 Hemoperfusion Market Challenges
13.4 Hemoperfusion Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemoperfusion Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Hemoperfusion Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Activated Carbon Adsorption
Table 3. Major Manufacturers of Resin Adsorption
Table 4. Global Hemoperfusion Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Hemoperfusion Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Hemoperfusion Sales by Regions (2016-2021) & (K Units)
Table 7. Global Hemoperfusion Sales Market Share by Regions (2016-2021)
Table 8. Global Hemoperfusion Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Hemoperfusion Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Hemoperfusion Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Hemoperfusion Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Hemoperfusion Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Hemoperfusion Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Hemoperfusion Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Hemoperfusion Manufacturers by Revenue (US$ Million) in 2020
Table 16. Hemoperfusion Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Hemoperfusion Revenue Share by Manufacturers (2016-2021)
Table 18. Global Hemoperfusion Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Hemoperfusion by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoperfusion as of 2020)
Table 20. Key Manufacturers Hemoperfusion Price (2016-2021) (USD/Unit)
Table 21. Hemoperfusion Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hemoperfusion Product Type
Table 23. Date of International Manufacturers Enter into Hemoperfusion Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemoperfusion Sales by Type (2016-2021) (K Units)
Table 26. Global Hemoperfusion Sales Share by Type (2016-2021)
Table 27. Global Hemoperfusion Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Hemoperfusion Revenue Share by Type (2016-2021)
Table 29. Hemoperfusion Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Hemoperfusion Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Hemoperfusion Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Hemoperfusion Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Hemoperfusion Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Hemoperfusion Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Hemoperfusion Sales by Application (2016-2021) (K Units)
Table 36. Global Hemoperfusion Sales Share by Application (2016-2021)
Table 37. Global Hemoperfusion Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Hemoperfusion Revenue Share by Application (2016-2021)
Table 39. Hemoperfusion Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Hemoperfusion Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Hemoperfusion Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Hemoperfusion Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Hemoperfusion Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Hemoperfusion Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China Hemoperfusion Sales (K Units) of Key Companies (2016-2021)
Table 46. China Hemoperfusion Sales Share by Company (2016-2021)
Table 47. China Hemoperfusion Revenue (US$ Million) by Company (2016-2021)
Table 48. China Hemoperfusion Revenue Share by Company (2016-2021)
Table 49. China Hemoperfusion Sales (K Units) by Type (2016-2021)
Table 50. China Hemoperfusion Sales Share by Type (2016-2021)
Table 51. China Hemoperfusion Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Hemoperfusion Price (USD/Unit) by Type (2016-2021)
Table 53. China Hemoperfusion Sales (K Units) by Type (2022-2027)
Table 54. China Hemoperfusion Sales Share by Type (2022-2027)
Table 55. China Hemoperfusion Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Hemoperfusion Revenue Share by Type (2022-2027)
Table 57. China Hemoperfusion Price (USD/Unit) by Type (2022-2027)
Table 58. China Hemoperfusion Sales (K Units) by Application (2016-2021)
Table 59. China Hemoperfusion Sales Share by Application (2016-2021)
Table 60. China Hemoperfusion Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Hemoperfusion Price (USD/Unit) by Application (2016-2021)
Table 62. China Hemoperfusion Sales (K Units) by Application (2022-2027)
Table 63. China Hemoperfusion Sales Share by Application (2022-2027)
Table 64. China Hemoperfusion Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Hemoperfusion Revenue Share by Application (2022-2027)
Table 66. China Hemoperfusion Price (USD/Unit) by Application (2022-2027)
Table 67. North America Hemoperfusion Sales by Country (2016-2021) & (K Units)
Table 68. North America Hemoperfusion Sales Market Share by Country (2016-2021)
Table 69. North America Hemoperfusion Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Hemoperfusion Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Hemoperfusion Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Hemoperfusion Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Hemoperfusion Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Hemoperfusion Revenue Market Share by Region (2016-2021)
Table 75. Europe Hemoperfusion Sales by Country (2016-2021) & (K Units)
Table 76. Europe Hemoperfusion Sales Market Share by Country (2016-2021)
Table 77. Europe Hemoperfusion Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Hemoperfusion Revenue Market Share by Country (2016-2021)
Table 79. Latin America Hemoperfusion Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Hemoperfusion Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Hemoperfusion Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Hemoperfusion Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Hemoperfusion Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Hemoperfusion Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Hemoperfusion Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Hemoperfusion Revenue Market Share by Country (2016-2021)
Table 87. Jafron Biomedical Corporation Information
Table 88. Jafron Biomedical Description and Business Overview
Table 89. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Jafron Biomedical Hemoperfusion Product
Table 91. Jafron Biomedical Recent Development
Table 92. Baxter (Gambro) Corporation Information
Table 93. Baxter (Gambro) Description and Business Overview
Table 94. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Baxter (Gambro) Product
Table 96. Baxter (Gambro) Recent Development
Table 97. Asahi-Kasei Corporation Information
Table 98. Asahi-Kasei Description and Business Overview
Table 99. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Asahi-Kasei Product
Table 101. Asahi-Kasei Recent Development
Table 102. Biosun Medical Corporation Information
Table 103. Biosun Medical Description and Business Overview
Table 104. Biosun Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Biosun Medical Product
Table 106. Biosun Medical Recent Development
Table 107. Kaneka Corporation Information
Table 108. Kaneka Description and Business Overview
Table 109. Kaneka Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Kaneka Product
Table 111. Kaneka Recent Development
Table 112. Toray Medical Corporation Information
Table 113. Toray Medical Description and Business Overview
Table 114. Toray Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Toray Medical Product
Table 116. Toray Medical Recent Development
Table 117. Cytosorbents Corporation Information
Table 118. Cytosorbents Description and Business Overview
Table 119. Cytosorbents Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Cytosorbents Product
Table 121. Cytosorbents Recent Development
Table 122. Aier Corporation Information
Table 123. Aier Description and Business Overview
Table 124. Aier Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Aier Product
Table 126. Aier Recent Development
Table 127. Zibo Kangbei Corporation Information
Table 128. Zibo Kangbei Description and Business Overview
Table 129. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Zibo Kangbei Product
Table 131. Zibo Kangbei Recent Development
Table 132. Hemoperfusion Market Trends
Table 133. Hemoperfusion Market Drivers
Table 134. Hemoperfusion Market Challenges
Table 135. Hemoperfusion Market Restraints
Table 136. Hemoperfusion Customers List
Table 137. Hemoperfusion Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemoperfusion Product Picture
Figure 2. Global Hemoperfusion Sales Market Share by Type in 2020 & 2027
Figure 3. Activated Carbon Adsorption Product Picture
Figure 4. Resin Adsorption Product Picture
Figure 5. Global Hemoperfusion Sales Market Share by Application in 2020 & 2027
Figure 6. Hepatic Encephalopathy
Figure 7. Certain Autoimmune Diseases
Figure 8. Drug Overdose
Figure 9. Specific Intoxications
Figure 10. Others
Figure 11. Hemoperfusion Report Years Considered
Figure 12. Global Hemoperfusion Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hemoperfusion Market Size 2016-2027 (US$ Million)
Figure 14. Global Hemoperfusion Sales 2016-2027 (K Units)
Figure 15. Global Hemoperfusion Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Hemoperfusion Sales Market Share by Region (2016-2021)
Figure 17. Global Hemoperfusion Sales Market Share by Region in 2020
Figure 18. Global Hemoperfusion Revenue Market Share by Region (2016-2021)
Figure 19. Global Hemoperfusion Revenue Market Share by Region in 2020
Figure 20. Global Hemoperfusion Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Hemoperfusion Revenue in 2020
Figure 22. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Hemoperfusion Sales Market Share by Type (2016-2021)
Figure 24. Global Hemoperfusion Sales Market Share by Type in 2020
Figure 25. Global Hemoperfusion Revenue Market Share by Type (2016-2021)
Figure 26. Global Hemoperfusion Revenue Market Share by Type in 2020
Figure 27. Global Hemoperfusion Sales Market Share by Application (2016-2021)
Figure 28. Global Hemoperfusion Sales Market Share by Application in 2020
Figure 29. Global Hemoperfusion Revenue Market Share by Application (2016-2021)
Figure 30. Global Hemoperfusion Revenue Market Share by Application in 2020
Figure 31. China Hemoperfusion Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Hemoperfusion Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Hemoperfusion Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Hemoperfusion Players Market Share by Revenue in Hemoperfusion in 2020
Figure 35. China Hemoperfusion Revenue Share by Type (2016-2021)
Figure 36. China Hemoperfusion Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Hemoperfusion Revenue Share by Application (2016-2021)
Figure 38. China Hemoperfusion Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Hemoperfusion Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Hemoperfusion Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Hemoperfusion Sales Market Share by Country in 2020
Figure 42. North America Hemoperfusion Revenue Market Share by Country in 2020
Figure 43. U.S. Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Hemoperfusion Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Hemoperfusion Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Hemoperfusion Sales Market Share by Country in 2020
Figure 50. Europe Hemoperfusion Revenue Market Share by Country in 2020
Figure 51. Germany Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Hemoperfusion Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Hemoperfusion Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Hemoperfusion Sales Market Share by Region in 2020
Figure 64. Asia Pacific Hemoperfusion Revenue Market Share by Region in 2020
Figure 65. China Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. China Taiwan Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 76. China Taiwan Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Latin America Hemoperfusion Sales Growth Rate 2016-2021 (K Units)
Figure 84. Latin America Hemoperfusion Revenue Growth Rate 2016-2021 (US$ Million)
Figure 85. Latin America Hemoperfusion Sales Market Share by Country in 2020
Figure 86. Latin America Hemoperfusion Revenue Market Share by Country in 2020
Figure 87. Mexico Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 88. Mexico Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Brazil Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 90. Brazil Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Argentina Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 92. Argentina Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Hemoperfusion Sales Growth Rate 2016-2021 (K Units)
Figure 94. Middle East and Africa Hemoperfusion Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Hemoperfusion Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Hemoperfusion Revenue Market Share by Country in 2020
Figure 97. Turkey Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 98. Turkey Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 100. Saudi Arabia Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Hemoperfusion Sales Growth Rate (2016-2021) (K Units)
Figure 102. UAE Hemoperfusion Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Hemoperfusion Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed
血液灌流生産の世界及び中国市場 Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material an…- 使い捨て型血液灌流の世界市場 2020年 Market Overview The Disposable Hemoperfusion market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界のポリマー吸着樹脂市場インサイト・予測（～2027年） Polymer adsorption resin refers to a type of high molecular polymer, which can be used to remove organic matter in wastewater, decolorize sugar liquid, separate and refine natural products and biochemical products, etc. Market Analysis and Insights: Global Polymer Adsorption Resin Market The global …
- 肝性脳症治療薬の世界市場 2020年 Market Overview The global Hepatic Encephalopathy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatic Encephalo…
- 炭素吸着システムの世界及び中国市場 A Carbon Adsorber is a type of pollution control equipment that is used to abate Volatile Organic Compounds (VOCs) in low concentration gas streams. Adsorption is a filtration method used to remove volatile organic compounds (VOCs) from waste gas streams. A Carbon Adsorber can be used when you are t…